Fact sheet: Invesco Global Health Care

Fund information
Fund name
Invesco Global Health Care A USD
Fund manager company
Invesco Global Asset Mgmt Ltd
Fund type
Unit Trust
Fund managers
  • Derek Tanersince 01/01/2006
Fund objective
The Fund aims to achieve long term capital growth by investing in shares of healthcare companies throughout the world. For the full objectives and investment policy please consult the current prospectus.
Benchmark
  • MSCI World Health Care
Investment style
Growth
Investment method
Shares
Quick stats
1 Year return
2.6%
1 Year rank in sector
27/31
Sector
FO Equity - Pharma Health & Biotech
Yield
-
Ongoing charge (OCF)
?A fund’s ongoing charges figure (OCF) is similar to the old-style total expense ratio. It reflects the annual charge to investors in the fund, in percentage terms, but does not include extra performance-related fees (where these are levied) or the fund’s trading expenses on its underlying investments.
2.44%
Fund size
£477m (£510m last year)
FE Risk score
?FE Risk Scores measure the riskiness of instruments relative to the FTSE 100 index of shares. Weekly volatility is measured over three years with recent behaviour counting more heavily than earlier behaviour. Cash-type investments will have scores close to zero. Funds will tend to have scores in the 0-150 range. The FTSE 100 is always scored at 100. There is no upper limit.
158
Top in this sector
Fund name1 Year
Pictet Biotech22.5%
Polar Capital Biotechnology21.4%
BB Medtech17.9%
Variopartner SICAV SeBiOpp17.7%
Fidelity Gbl Health Care16.9%
...more in FO Equity - Pharma Health & Biotech

Performance snapshot

Holdings snapshot

  • USA80.1%
    Switzerland5.1%
    France3%
    Japan2.7%
    Ireland2.2%
  • Biotechnology/Medical42.7%
    Pharmaceuticals30.4%
    Health Care16.8%
    Healthcare & Medical Products4.4%
    Others3.3%
  • US Equities80.1%
    Swiss Equities5.1%
    French Equities3%
    Japanese Equities2.7%
    Irish Equities2.2%

Performance vs Sector

Cumulative performance
 1 mth3 mth6 mth1 yr3 yr5 yr
Fund1.8%7.4%7.8%2.6%11.5%63.5%
Sector0.9%7.9%9.6%8.9%34.4%104.1%
Rank within sector8 / 3118 / 3120 / 3127 / 3125 / 2824 / 24
Quartile2nd3rd3rd4th4th4th
Calendar performance
 YTD - 20172016201520142013
Fund9%-13.5%1%19.3%37.5%
Sector10.2%-9.9%7.2%28.1%41%
Rank within sector19 / 3119 / 3128 / 2923 / 2613 / 24
Quartile3rd3rd4th4th3rd
Risk statistics
Alpha
?Alpha is a measure of a fund's over- or under-performance by comparison to its benchmark. If the Alpha is 5, the fund has outperformed its benchmark by 5%; so the greater the Alpha, the greater the outperformance.
-5
Beta
?Beta estimates a fund's volatility by comparison to that of its benchmark. A fund with a beta close to 1 means that the fund will move generally in line with the benchmark. Higher than 1 and the fund is more volatile than the benchmark and vice versa.
0.99
Sharpe
?This commonly-used measure calculates the level of return over and above the return of a notional risk-free investment, such as cash. The difference in returns is then divided by the fund's volatility. The resulting ratio is an indication of the amount of excess return generated per unit of risk.
-0
Volatility
?Volatility (or standard deviation), when applied to an investment fund, expresses its risk. It shows how widely a range of returns varied from the fund's average return over a particular period. For example, if a fund had an average return of 5%, and its volatility was 15, this would mean that the range of its returns over the period had swung between +20% and -10%.
16.33
Tracking error
?This measures the standard deviation of a fund's excess returns over the returns of an index or benchmark portfolio. As such, it can be an indication of 'riskiness' in the manager's investment style. A Tracking Error below 2 suggests a passive approach. At 3 and above the the manager will be deploying a more active investment style.
5.07
Information ratio
?This is a useful risk-adjusted measure of actively managed fund performance. It is calculated by deducting the returns of the fund's benchmark from the fund's overall returns, then dividing the result by its tracking error. The higher the Information Ratio the better. It is generally considered that a figure of 0.5 reflects a good performance, 0.75 very good, and 1.00 outstanding.
-1.02
R-Squared
?An indication of how closely correlated a fund is to an index or a benchmark. Values for R-Squared range between 0 and 1, with 0 indicating no correlation at all and 1 showing a perfect match. Values upwards of 0.7 suggest that the fund's behaviour is increasingly linked to its benchmark.
0.9
Price movement
52 week high124.83
52 week low106.49
Current bid price-
Current offer price-
Current mid price122.76
Region
1USA80.1%
2Switzerland5.1%
3France3%
4Japan2.7%
5Ireland2.2%
6Money Market1.9%
7Germany1.6%
8Others1.3%
9UK1.1%
Industry sector
1Biotechnology/Medical42.7%
2Pharmaceuticals30.4%
3Health Care16.8%
4Healthcare & Medical Products4.4%
5Others3.3%
6Money Market1.9%
7Food & Drug Retailers0.5%
Asset type
1US Equities80.1%
2Swiss Equities5.1%
3French Equities3%
4Japanese Equities2.7%
5Irish Equities2.2%
6Money Market1.9%
7German Equities1.6%
8International Equities1.3%
9UK Equities1.1%
Individual holdings
1CELGENE CORP6%
2LILLY (ELI) & CO5.4%
3SHIRE PLC5%
4MERCK & CO INC(NEW)4%
5THERMO FISHER SCIENTIFIC INC4%
6BIOGEN INC3.7%
7BIOMARIN PHARMACEUTICAL3.5%
8ROCHE HLDG AG2.9%
9INCYTE CORP2.7%
Management
Fund manager group
Invesco Perpetual
Fund manager company
Invesco Global Asset Mgmt Ltd
Fund type
Unit Trust
Fund objective
The Fund aims to achieve long term capital growth by investing in shares of healthcare companies throughout the world. For the full objectives and investment policy please consult the current prospectus.
Benchmark
  • MSCI World Health Care
Investment style
Growth
Investment method
Shares
Fund managers
NameSinceBiography
Derek Taner01/01/2006Based in San Francisco in the US, Derek is responsible for the management of a number of sector portfolios, specialising in the healthcare sector. Derek began his investment career in 1993 as a fixed-income analyst with Franklin Templeton and was promoted to assistant portfolio manager in 1997. In 2000, he joined the firm’s equity department and was named co-manager of its equity-income portfolios. Before joining our company in 2005, Derek was working as a portfolio manager for Franklin Templeton’s health care fund from 2002 through 2005 — the final two years as lead manager. Derek earned a BSc degree in business administration with an emphasis in accounting and finance and a Master of Business Administration degree from the Haas School of Business at the University of California (Berkeley). He holds the Chartered Financial Analyst® (CFA®) designation.
Compliance
Transparent for Austrian Tax, Transparent for Swiss Tax, Transparent for German Tax, Distributor Status, IA Recognised, Reporting Fund Status, UCITS IV Compliant
Domicile
No data available.
Fund for sale in
Austria, Switzerland, Germany, Spain, Finland, France, United Kingdom, Gulf Cooperation Council, Greece, Guernsey, Hong Kong, Ireland, Jersey, Luxembourg, Macau, Netherlands, Norway, Offshore, Singapore, Sweden, Taiwan - Province Of China
Invesco Global Health Care A USD
Initial charge5.26%
Annual charge2%
Min single investment£1,500
Min regular saving£500
Available in ISANo
Ongoing charge (OCF)2.44%
Total expense ratio (TER)2.52%
Bid price-
Offer price-
Mid price122.76
CurrencyUSD
Price updated26/04/2017
TypeIncome
Institutional or retail classRetail
Domicile-
Citi codeGV48
Invesco Global Health Care B USD
Initial charge-
Annual charge2%
Min single investment£1,500
Min regular saving£0
Available in ISANo
Ongoing charge (OCF)3.34%
Total expense ratio (TER)3.41%
Bid price-
Offer price-
Mid price104.37
CurrencyUSD
Price updated26/04/2017
TypeIncome
Institutional or retail classRetail
Domicile-
Citi codeIHQ6
Invesco Global Health Care C USD
Initial charge5.26%
Annual charge1.5%
Min single investment£1,000,000
Min regular saving£0
Available in ISANo
Ongoing charge (OCF)1.84%
Total expense ratio (TER)1.87%
Bid price-
Offer price-
Mid price138.93
CurrencyUSD
Price updated26/04/2017
TypeIncome
Institutional or retail classInstitutional
Domicile-
Citi codeGV54
Invesco Global Health Care Z Annual Dis USD
Initial charge5.26%
Annual charge1%
Min single investment£1,500
Min regular saving£0
Available in ISANo
Ongoing charge (OCF)1.44%
Total expense ratio (TER)-
Bid price-
Offer price-
Mid price13.2
CurrencyUSD
Price updated26/04/2017
TypeIncome
Institutional or retail classRetail
Domicile-
Citi codeFASM
Data provided by

The Content is only for your general information and use and is not intended to address your particular requirements. The Content does not constitute any form of advice, recommendation or arrangement by Moneywise and is not intended to be relied upon by you in making (or refraining from making) any specific investment or other decisions. Appropriate independent advice should be obtained before making any such decision.

This information is sourced from our partner Financial Express. We believe the data to be correct however you should take care in using any information.

You should be aware that prices may fall as well as rise and that the income derived can go down as well as up. When buying or selling any investment that fluctuates in price or value you may get back less than you invested. Past performance is not necessarily a guide to future performance.